Macrophages use cell‑volume changes to sense danger, reprogram gene expression, and heighten inflammatory and antiviral responses.

The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

In this GEN webinar, Alex Zevin, PhD, director of Fred Hutchinson Cancer Center’s Genomics Shared Resource, draws on hands-on experience with managing a suite of nucleic acid quantification ...

Last month, the AGBT Agricultural Meeting was held in Phoenix, Arizona. The conference is focused on agricultural genomics—plant and animal genetics. During the meeting, the recipients of the 2026 ...

This eBook brings together perspectives from Genetic Engineering News and ElevateBio to examine both the technical and ...

CoCoGraph uses a diffusion model, a technique common in image generation, to generate realistic molecules for therapeutics ...

Prolific Machines technology gives developers precise, real-time control over when and how much protein a cell produces.

Symmetric, heavy-chain BsAbs are more productive and faster-growing, with higher purity output, than asymmetric, light-chain, or DVD antibodies.

NN4101, a first-in-class, connects a fully human anti-c-Kit monoclonal antibody with a vascular endothelial growth factor ...

IFPMA, has called for greater inspection reliance between regulatory agencies to help biopharmaceutical companies reduce GMP ...

Peptide ligands can remove process- and product-related impurities from gene therapies better than protein ligands.

At Germany-based Eleva, researchers are using Physcomitrium patens, a simple moss species, as a suspension cell culture system for producing recombinant human proteins that are difficult and sometimes ...